Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Jet2 cuts winter capacity and forecasts lower profit growth for 2026 amid a less certain consumer environment and higher costs.
Two women arrested for racial abuse during Sky News interview with local businessman in Nuneaton.
Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Jet2 cuts winter capacity and forecasts lower profit growth for 2026 amid a less certain consumer environment and higher costs.
Two women arrested for racial abuse during Sky News interview with local businessman in Nuneaton.